Pacira BioSciences Inc (NAS:PCRX)
$ 17.24 -0.46 (-2.6%) Market Cap: 796.03 Mil Enterprise Value: 986.64 Mil PE Ratio: 0 PB Ratio: 1.06 GF Score: 71/100

Pacira Biosciences Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 01:30PM GMT
Release Date Price: $37.54 (-3.94%)
Glen Santangelo;David
Jefferies - Analyst

Good morning, everybody. Thanks for joining us. Why don't we get started. For our next presentation, we're excited to have Pacira BioSciences here with us. Representing the company is the CEO and Chairman to my left, David Stack; and in the front row here, Susan Mesco, who heads the Investor Relations function for the company. So if anybody has any questions, I'm sure she would love to hear from you, and you can always reach out to us.

For those of you who don't know me, I'm Glen Santangelo. I cover the specialty pharmaceutical and healthcare information technology sectors at Credit Suisse. So with that out of the way, why don't we begin? And for those on the webcast, thanks for joining us.

If you do have any questions, please feel free to e-mail me. I'll try to work them in. And we do have a mic in the room, so if anybody has a question, you can raise your hand, and we can get you a mic. And fortunately, you need to speak into the mic as we are webcasting.

All right, why don't we get started? Dave, thanks, welcome.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot